Pharmaceuticals

Tue, 08/31/2010 - 13:48

Anke Bio to purchase anticancer drug for $1.69 mln

Shanghai. August 31. INTERFAX-CHINA - Anhui Anke Biotechnology (Group) Co. Ltd. has agreed to purchase production technology and a new drug certificate for the TS-1 tablet, an anticancer drug, from Hefei Yigong Medicine Co. Ltd. for RMB 11.5 million ($1.69 million), Anke Bio announced Aug. 27.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW